Literature DB >> 32008963

Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus.

P Chen1, J Liu1, M Zeng1, H Sang2.   

Abstract

Aspergillus infections are increasingly recognized as a global health problem because of limited antifungal drugs and occurrence of azole resistance worldwide. More cyp51-mediated and non-cyp51-mediated mechanisms of azole resistance have been identified in clinical and laboratory studies in recent years with applications of molecular biotechnology including next-generation sequencing, reverse genetics and so on. In this review, current research on the molecular mechanisms of azole resistance in A. fumigatus were presented and summarized and meanwhile the putative clinical relevance of these findings from bench work were discussed. Important aims are to gain more insight to mechanism of azole resistance and provide some efficient lead for prevention strategy.
Copyright © 2019. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Aspergillus fumigatus; Azole resistance; Non-cyp51 mutation; Pathogenic fungi; cyp51 mutation

Mesh:

Substances:

Year:  2019        PMID: 32008963     DOI: 10.1016/j.mycmed.2019.100915

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  9 in total

1.  Electron donor cytochrome b5 is required for hyphal tip accumulation of sterol-rich plasma membrane domains and membrane fluidity in Aspergillus fumigatus.

Authors:  Chi Zhang; Yiran Ren; Lu Gao; Huiyu Gu; Ling Lu
Journal:  Appl Environ Microbiol       Date:  2020-11-30       Impact factor: 4.792

2.  Long Terminal Repeat Retrotransposon Afut4 Promotes Azole Resistance of Aspergillus fumigatus by Enhancing the Expression of sac1 Gene.

Authors:  Mandong Hu; Zongwei Li; Dingchen Li; Jingya Zhao; Yong Chen; Zelei Wang; Fangyan Chen; Li Han
Journal:  Antimicrob Agents Chemother       Date:  2021-09-13       Impact factor: 5.191

3.  Azole Resistance in Clinical and Environmental Aspergillus Isolates from the French West Indies (Martinique).

Authors:  Lorra Monpierre; Nicole Desbois-Nogard; Isabel Valsecchi; Marielle Bajal; Cécile Angebault; Charline Miossec; Françoise Botterel; Éric Dannaoui
Journal:  J Fungi (Basel)       Date:  2021-04-30

Review 4.  Detecting Azole-Antifungal Resistance in Aspergillus fumigatus by Pyrosequencing.

Authors:  Mireille H van der Torre; Lilyann Novak-Frazer; Riina Rautemaa-Richardson
Journal:  J Fungi (Basel)       Date:  2020-01-10

5.  Azole Resistance and cyp51A Mutation of Aspergillus fumigatus in a Tertiary Referral Hospital in Taiwan.

Authors:  Tsun-Hao Hsu; Po-Yen Huang; Yun-Chen Fan; Pei-Lun Sun
Journal:  J Fungi (Basel)       Date:  2022-08-26

6.  Identification of Novel Mutations Contributing to Azole Tolerance of Aspergillus fumigatus through In Vitro Exposure to Tebuconazole.

Authors:  Takahito Toyotome; Kenji Onishi; Mio Sato; Yoko Kusuya; Daisuke Hagiwara; Akira Watanabe; Hiroki Takahashi
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

7.  Analysis of the cyp51 genes contribution to azole resistance in Aspergillus section Nigri with the CRISPR-Cas9 technique.

Authors:  Alba Pérez-Cantero; Adela Martin-Vicente; Josep Guarro; Jarrod R Fortwendel; Javier Capilla
Journal:  Antimicrob Agents Chemother       Date:  2021-03-08       Impact factor: 5.191

8.  CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi.

Authors:  N Van Rhijn; M Bromley; M Richardson; P Bowyer
Journal:  mBio       Date:  2021-10-05       Impact factor: 7.867

9.  Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.

Authors:  Thaila Fernanda Dos Reis; Maria Augusta Crivelente Horta; Ana Cristina Colabardini; Caroline Mota Fernandes; Lilian Pereira Silva; Rafael Wesley Bastos; Maria Vitória de Lazari Fonseca; Fang Wang; Celso Martins; Márcio L Rodrigues; Cristina Silva Pereira; Maurizio Del Poeta; Koon Ho Wong; Gustavo H Goldman
Journal:  mBio       Date:  2021-08-10       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.